RCM
RA Capital Management Portfolio holdings
AUM
$9.44B
1-Year Est. Return
157.3%
This Fund
S&P 500
1 Year Est. Return
+157.3%
AUM
$9.76B
AUM Growth
+$1.65B
(+20%)
Holding
88
Top Buys
| 1 | +$114M | |
| 2 | +$105M | |
| 3 | +$72M | |
| 4 |
Praxis Precision Medicines
PRAX
|
+$69.6M |
| 5 |
EVMN
Evommune Inc
EVMN
|
+$65M |
Top Sells
| 1 | +$292M | |
| 2 | +$141M | |
| 3 | +$55.5M | |
| 4 |
BLTE
Belite Bio
BLTE
|
+$52.4M |
| 5 |
Dianthus Therapeutics
DNTH
|
+$48.7M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
uniQure
QURE
$1.8B
| – | – |
-200,000
|
|
||
77
Larimar Therapeutics
LRMR
$362M
| – | – |
-6,045,351
|
|
||
78
InflaRx
IFRX
$354M
| – | – |
-1,973,233
|
|
||
|
EXAS
79
DELISTED
Exact Sciences
EXAS
| – | – |
-54,939
|
|
||
|
MTSR
80
DELISTED
Metsera Inc
MTSR
| – | – |
-675,525
|
|
||
81
Travere Therapeutics
TVTX
$4.39B
| – | – |
-1,150,000
|
|
||
82
Prime Medicine
PRME
$641M
| – | – |
-3,000,000
|
|
||
83
Glaukos
GKOS
$6.07B
| – | – |
-54,180
|
|
||
84
Structure Therapeutics
GPCR
$2.8B
| – | – |
-1,517,418
|
|
||
85
Evolent Health
EVH
$444M
| – | – |
-579,052
|
|
||
|
ETNB
86
DELISTED
89bio
ETNB
| – | – |
-19,889,683
|
|
||
87
Eledon Pharmaceuticals
ELDN
$294M
| – | – |
-3,566,338
|
|
||
88
CytomX Therapeutics
CTMX
$784M
| – | – |
-2,661,331
|
|